We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+17.61%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$556M
AUM Growth
+$28.1M
(+5.3%)
Cap. Flow
-$40.2M
Cap. Flow
% of AUM
-7.23%
Top 10 Holdings %
Top 10 Hldgs %
17.22%
Holding
230
New
38
Increased
44
Reduced
92
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Bancorp
TBBK
|
+$6.97M |
| 2 |
LNW
Light & Wonder
LNW
|
+$6.69M |
| 3 |
e.l.f. Beauty
ELF
|
+$4.06M |
| 4 |
CONMED
CNMD
|
+$4.04M |
| 5 |
ESCO Technologies
ESE
|
+$4.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinsale Capital Group
KNSL
|
+$11.6M |
| 2 |
HealthEquity
HQY
|
+$6.56M |
| 3 |
ALE
Allete
ALE
|
+$4.77M |
| 4 |
Hilton Grand Vacations
HGV
|
+$4.72M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$4.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.18% |
| 2 | Healthcare | 16.22% |
| 3 | Technology | 15.16% |
| 4 | Industrials | 13.7% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Alnylam Pharmaceuticals
ALNY
$29.3B
| $629K | 0.11% |
3,285
+1,002
| +44% | +$171K |
|
|
EXAS
127
DELISTED
Exact Sciences
EXAS
| $627K | 0.11% |
8,477
+2,996
| +55% | +$196K |
|
128
Celldex Therapeutics
CLDX
$3.28B
| $582K | 0.1% |
14,687
| – | – |
|
129
East-West Bancorp
EWBC
$18B
| $579K | 0.1% |
8,054
-18
| -0.2% | -$1.08K |
|
130
UnitedHealth
UNH
$370B
| $573K | 0.1% |
1,088
-50
| -4% | -$26.7K |
|
131
Bio-Techne
TECH
$11.3B
| $490K | 0.09% |
6,351
+2,576
| +68% | +$170K |
|
132
Stryker
SYK
$130B
| $486K | 0.09% |
1,622
-153
| -9% | -$42.9K |
|
133
Blackstone
BX
$110B
| $483K | 0.09% |
3,687
+30
| +0.8% | +$3.25K |
|
134
JPMorgan Chase
JPM
$950B
| $481K | 0.09% |
2,828
+187
| +7% | +$28.3K |
|
135
Gilead Sciences
GILD
$165B
| $475K | 0.09% |
5,858
| – | – |
|
136
Deckers Outdoor
DECK
$13.3B
| $465K | 0.08% |
4,170
-2,982
| -42% | -$303K |
|
137
Incyte
INCY
$24.4B
| $463K | 0.08% |
7,371
| – | – |
|
138
PepsiCo
PEP
$190B
| $454K | 0.08% |
2,676
+485
| +22% | +$80.4K |
|
139
Teledyne Technologies
TDY
$32B
| $447K | 0.08% |
1,001
-1
| -0.1% | -$401 |
|
140
United Therapeutics
UTHR
$23.1B
| $445K | 0.08% |
2,024
| – | – |
|
|
141
Kinsale Capital Group
KNSL
$8.51B
| $437K | 0.08% |
1,304
-31,226
| -96% | -$11.6M |
|
142
Broadridge
BR
$19B
| $427K | 0.08% |
2,076
+5
| +0.2% | +$922 |
|
|
SF
143
Stifel
SF
$12.6B
| $426K | 0.08% |
9,242
-25
| -0.3% | -$1.03K |
|
144
AppFolio
APPF
$7.04B
| $423K | 0.08% |
+2,441
| New | +$457K |
|
145
Boston Scientific
BSX
$71.5B
| $421K | 0.08% |
7,285
-516
| -7% | -$27.5K |
|
146
Xenon Pharmaceuticals
XENE
$6.12B
| $420K | 0.08% |
9,123
| – | – |
|
147
Pool Corp
POOL
$7.5B
| $417K | 0.08% |
1,046
-2
| -0.2% | -$701 |
|
148
Advanced Drainage Systems
WMS
$10.9B
| $410K | 0.07% |
2,912
-8
| -0.3% | -$964 |
|
149
Pultegroup
PHM
$25.3B
| $408K | 0.07% |
+3,956
| New | +$336K |
|
150
Alphabet (Google) Class A
GOOGL
$4.33T
| $401K | 0.07% |
2,874
| – | – |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Moody Aldrich Partners held 230 positions worth $556M, up 5.3% from $528M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Moody Aldrich Partners withdrew a net $40.2M in Q4 2023, closing 35 positions and reducing 92 holdings. Its most notable exit was HealthEquity, an estimated $6.56M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Moody Aldrich Partners opened a new position in The Bancorp worth $7.18M.
- Moody Aldrich Partners's largest Q4 2023 buy was The Bancorp: 186,299 shares worth $7.18M.
- Moody Aldrich Partners added most to Leonardo DRS in Q4 2023, an estimated $3.28M increase.
- Moody Aldrich Partners's biggest Q4 2023 reduction was Kinsale Capital Group, cutting an estimated $11.6M.
- Moody Aldrich Partners fully exited HealthEquity in Q4 2023, selling an estimated $6.56M.
- Moody Aldrich Partners's ten largest holdings make up 17% of its $556M portfolio in Q4 2023.
- Moody Aldrich Partners opened 38 new positions and closed 35 in Q4 2023.
- Moody Aldrich Partners's portfolio value rose 5.3% quarter-over-quarter to $556M.
Based on Moody Aldrich Partners's 13F filing for Q4 2023, filed 26 Jan 2024.